Batch test results
Every GLP-123 batch with a published third-party Certificate of Analysis, in one table. Purity is measured by HPLC; content is the amount of peptide actually found in the vial.
21batches published
99.72%average HPLC purity
range 99.4–99.9%
range 99.4–99.9%
112.9%average content vs label
lowest 100.6%
lowest 100.6%
0batches below label claim
In short: across 21 batches tested between November 2025 and June 2026, average HPLC purity was 99.72% and no batch contained less peptide than its label states.
By compound
| Compound | Batches | Avg purity | Purity range | Avg content vs label |
|---|---|---|---|---|
| Retatrutide | 6 | 99.68% | 99.4–99.9% | 111.2% |
| Tirzepatide | 12 | 99.71% | 99.4–99.9% | 112.7% |
| Semaglutide | 3 | 99.87% | 99.8–99.9% | 117.7% |
Every batch
| Lot | Compound | Label | Measured | % of label | HPLC purity | Tested |
|---|---|---|---|---|---|---|
| GLP3_20_2 ! | Retatrutide | 5 mg | 5.1 mg | 102.7% | 99.7% | 2026-06-08 |
| R5-001 | Retatrutide | 5 mg | 5.99 mg | 119.8% | 99.4% | 2026-06-08 |
| R10-001 | Retatrutide | 10 mg | 11.02 mg | 110.2% | 99.9% | 2025-11-01 |
| GLP3_10_2 | Retatrutide | 10 mg | 10.5 mg | 105.0% | 99.6% | 2026-06-08 |
| R20-001 | Retatrutide | 20 mg | 23.1 mg | 115.5% | 99.8% | 2025-11-01 |
| GLP3_20_2 | Retatrutide | 20 mg | 22.7 mg | 113.7% | 99.7% | 2026-06-08 |
| TZ05.001 | Tirzepatide | 5 mg | 5.58 mg | 111.6% | 99.4% | 2025-11-01 |
| TL10.001 | Tirzepatide | 10 mg | 10.06 mg | 100.6% | 99.7% | 2025-11-01 |
| TH10.001 | Tirzepatide | 10 mg | 10.06 mg | 100.6% | 99.7% | 2025-11-01 |
| TZ15.00 ! | Tirzepatide | 15 mg | 17.41 mg | 116.1% | 99.4% | 2025-11-01 |
| TZ20.01 | Tirzepatide | 20 mg | 22.7 mg | 113.5% | 99.8% | 2025-11-01 |
| TZ30.001 | Tirzepatide | 30 mg | 33.6 mg | 112.0% | 99.9% | 2025-11-01 |
| GLP2-30_02 | Tirzepatide | 30 mg | 34.4 mg | 114.8% | 99.7% | 2026-06-29 |
| TL40.001 | Tirzepatide | 40 mg | 45.42 mg | 113.6% | 99.7% | 2025-11-01 |
| TL50.001 | Tirzepatide | 50 mg | 58.45 mg | 116.9% | 99.8% | 2025-11-01 |
| GLP2-50_02 ! | Tirzepatide | 50 mg | 50 mg | 119.9% | 99.8% | 2026-06-29 |
| T060.001 | Tirzepatide | 60 mg | 71.57 mg | 119.3% | 99.8% | 2025-11-01 |
| GLP2-60_01 | Tirzepatide | 60 mg | 67.8 mg | 113.1% | 99.8% | 2026-06-29 |
| S5-001 | Semaglutide | 5 mg | 5.7 mg | 114.0% | 99.9% | 2025-11-01 |
| S10-001 | Semaglutide | 10 mg | 11.8 mg | 118.0% | 99.8% | 2025-11-01 |
| S20-001 | Semaglutide | 20 mg | 24.2 mg | 121.0% | 99.9% | 2025-11-01 |
Figures are transcribed from each signed certificate; click a lot for its page and the original certificate. Lots marked ! have an inconsistency on the certificate itself. Full certificates: glp-123.com COA page.